CITRAPHOS

About

CITRAPHOS is a phosphate binder medication used primarily to manage hyperphosphatemia, a condition characterized by abnormally high levels of phosphate in the blood. This condition is commonly seen in patients with chronic kidney disease (CKD), especially those on dialysis, as their kidneys are unable to effectively excrete excess phosphate. CITRAPHOS works by binding to dietary phosphate in the gastrointestinal tract, forming insoluble complexes that are then excreted in the feces.

By reducing the absorption of phosphate from food, CITRAPHOS helps to lower serum phosphate levels, which is crucial for preventing complications such as mineral and bone disorders, cardiovascular calcification, and other adverse outcomes associated with hyperphosphatemia in CKD patients. Consistent adherence to the prescribed regimen is vital for effective management.

Uses

• Treatment of hyperphosphatemia in chronic kidney disease
• Management of elevated serum phosphate in dialysis patients
• Prevention of mineral and bone disorders in CKD
• Control of phosphate levels in end-stage renal disease

Directions For Use

Take with meals or snacks, as directed by your physician, to maximize phosphate binding.

Benefits

• Effectively lowers serum phosphate levels
• Helps prevent mineral bone disease
• Reduces the risk of cardiovascular calcification
• Improves bone health in CKD patients
• Supports overall kidney health management
• Minimizes complications of hyperphosphatemia

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Dyspepsia (indigestion)
• Flatulence
• Hypercalcemia (if calcium-based binder)
• Hypophosphatemia (if over-dosed)
• Metallic taste
• Headache
• Dizziness

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol consumption can impact nutritional status and overall health in CKD patients.
• Pregnancy - Use only if clearly needed and the potential benefits outweigh the risks. Consult your doctor before use.
• Breastfeeding - Use with caution and under medical supervision. It is important to discuss with your doctor.
• Liver - Generally safe for use in patients with liver conditions, as its primary action is within the gastrointestinal tract.
• Kidney - Specifically used for kidney conditions (hyperphosphatemia in CKD). Close monitoring of serum phosphate and calcium levels is essential.
• Lung - Generally safe, with no specific lung-related precautions or adverse effects commonly reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.